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Abstract. We define and examine a model of epidemic propagation for a virus such
as Hepatitis C (with HIV co-infection) on a network of networks, namely the network
of French urban areas. One network level is that of the individual interactions inside
each urban area. The second level is that of the areas themselves, linked by individuals
travelling between these areas and potentially helping the epidemic spread from one
city to another. We choose to encode the second level of the network as extra, special
nodes in the first level. We observe that such an encoding leads to sensible results in
terms of the extent and speed of propagation of an epidemic, depending on its source
point.
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1. Introduction
Modelling the propagation of epidemics is a long-standing endeavour in the medical and
mathematical sciences. In the past decade or so, multiple developments in the science
of complex systems in general, and networks in particular, have led to new models,
along with the possibility to test their predictions on datasets, the size of which keeps
increasing (see for instance [1, 2] and references therein).
Particularly challenging are the study and modeling of epidemics involving specific,
sometimes marginal, segments of the general population. For instance, viruses and
diseases that are particularly prevalent among people who inject drugs (PWID). Things
become even more involved if one tries to take into account correlations between
interrelated epidemics, such as Hepatitis C virus (HCV) and AIDS (HIV) among PWID
populations [3].
In this paper, we introduce a simple model of propagation for HCV, with potential
HIV co-infection, on a network of networks, representing PWID populations in distinct
but interconnected urban areas. This model is intended as a first step towards a
more comprehensive model, and to serve as a basis for comparison with public health
statistical data when it becomes available.
In our model, the PWID population of each urban area is a network of individuals,
and the fact that people may travel or even move houses from one city to another makes
for a second level of links, between cities themselves. We choose to represent this second
level via the introduction of special nodes at the first level, that will represent at the
individual level in each city, contacts with individuals from other cities. This means that
if cities A and B are linked (in the sense that a number of individuals travel from one of
them to the other), then we add a node in the network representing individuals in city
A. The degree and other characteristics of this special node in city A will depend on the
number of individuals from city B travelling to city A and on the size of the infected
population in city B. This makes for a simple treatment of the links between cities.
We also adapt the standard susceptible-infected-recovered (SIR) equations to reflect the
specifics of the HCV epidemics with possible HIV co-infection, as well as to take into
account the special type of network with which we are working. The construction of
this simple model is detailed in Section 2 and 3.
In Section 4, we examine, via numerical simulations, how our model works, first
on a toy-country with just three cities and then on the network of France’s 100 largest
urban areas. We find that simulations run for different values of the parameters lead
to sensible stylized facts in terms of the extent and speed of propagation of an HCV
epidemics in France.
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Figure 1: Compartmental model of HCV’s natural history.
S, susceptible; A, acute HCV infection; C, chronic HCV infection; D, death from HCV.
2. Epidemic models
2.1. Initial model of the spread of Hepatitis C
Let us consider the compartmental model describing the infection dynamics of
Hepatitis C virus (HCV) displayed in Figure 1. This model is based on a susceptible-
infected-susceptible (SIS) model which is a derivative of the classic susceptible-infected-
recovered (SIR) model introduced in [4].
We denote by S the number of susceptible individuals, by A the number of
individuals in the acute phase of the infection and by C the number of individuals in
the chronic phase of the infection. Assuming that the number of individuals in the total
population is constant over time, which is not a strong assumption for large populations,
we write S(t) + A(t) + C(t) = N . In particular, we assume that the number of people
who died from HCV or from some other cause equals the number of people joining the
population as new susceptibles.
From now on, we work in terms of proportions rather than absolute numbers. The
proportion of susceptible, acute-HCV infected and chronic-HCV infected at time t are
denoted by s(t), a(t) and c(t) respectively. Writing β for the transmission rate, γ for the
recovery rate, δ for the death rate, µ for the natural mortality rate, Λ for the joining
rate, 1/σ for the duration of the acute phase and p for the spontaneous clearance, i.e.
the probability that a given individual clears the infection, one can write the following
set of differential equations:
ds(t)
dt
= Λ− βs(t)(a(t) + c(t)) + pσa(t) + γc(t)− µs(t),
da(t)
dt
= βs(t)(a(t) + c(t))− (σ + µ)a(t),
dc(t)
dt
= (1− p)σa(t)− (γ + δ + µ)c(t).
(2.1)
Since HCV is an asymptomatic disease, very limited individuals are diagnosed
during the acute phase of the infection. Thus we assume that only individuals in the
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Figure 2: Network of PWID infected by HCV and their sharing partners.
Blue nodes represent susceptible individuals, yellow nodes represent individuals in the
acute phase of HCV, red nodes represent individuals in the chronic phase of HCV and
black nodes are individuals who died from HCV.
chronic phase have access to a treatment, and only people in the chronic phase can
recover.
Note that the transmission rate β may be written as β = ω × pi, where ω is the
contact rate (the number of contacts per unit time) and pi the transmission risk (the
risk of infection for a given contact). Moreover, as not every patient is actually treated,
γ may be written as γ = ν × q where ν is the recovery rate per patient and q the
proportion of treated patients.
The model defined in the set of equations (2.1), also called mass action model, offers
a simple and convenient manner of describing the dynamics of an epidemic in a large
population. However, it fails to incorporate population heterogeneities and individual
interactions that may greatly affect the virus’s rate of transmission.
Regarding HCV, it has been stated that the primary route of transmission in the
developed world is intravenous drug use (IDU) [5]. As people who inject drugs (PWID)
tend to share drug injecting equipment with a limited number of partners (see for
example the social network described in [6]), using a simple mass action model might
by questionable.
Hence, assuming that individuals with the same number of sharing partners present the
same risk in the infectious process, we opt for the heterogeneous mean field approach,
first introduced in [7]. Each individual is assigned a degree (a number of partners) k,
where 1 6 k 6 N − 1, and constitutes an element of the network (also referred to as a
node, in graph theory). As individuals with 0 partner do not contribute to the spread
of the epidemic, only individuals with at least one partner will be considered. Figure 2
offers a visual representation of a static network of sharing partners infected by HCV.
For every individual dying of HCV, it is assumed that a new susceptible individual
enters the network, substituting for them.
Let us denote by ρ the degree distribution, i.e. ρ(k) is the proportion of individuals
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with degree k. Writing sk(t) (resp. ak(t) and ck(t)) for the proportion of susceptible
(resp. acute-HCV infected and chronic-HCV infected) individuals with degree k at
time t, one has:
s(t) =
N−1∑
k=1
sk(t), a(t) =
N−1∑
k=1
ak(t), c(t) =
N−1∑
k=1
ck(t). (2.2)
Referring now to [7], the proportion of infected partners for an individual with degree
k is given by:
θk(t) =
N−1∑
k′=1
ρN(k
′|k) (ak′(t) + ck′(t))
where ρN(k
′|k) is the proportion of partners with degree k′ among all partners of an
individual with degree k. Under the assumption that all nodes of a given degree are
statistically equivalent, one finds that ρN(k
′|k) = (k′ρ(k′)) /〈k〉, where 〈k〉 is the mean
degree of the network [8]. As ρN(k
′|k) then does not depend on k, we shall simply write
ρN(k
′). Thus (2.1) becomes:
dsk(t)
dt
= Λ− kβsk(t)θk(t) + pσak(t) + γck(t)− µsk(t), (2.3)
dak(t)
dt
= kβsk(t)θk(t)− (σ + µ)ak(t), (2.4)
dck(t)
dt
= (1− p)σak(t)− (γ + δ + µ)ck(t). (2.5)
To determine which degree distribution should be used to model the drug equipment
sharing pattern between PWID, we refer to [9] and [10]. The authors study the social
network of PWID in the Bushwick neighborhood in Brooklyn, New York, and analyse
its degree distribution. This analysis showed that the resulting degree distribution could
be assimilated to a power law distribution. Typical of scale-free networks, power law
distributions reflect a preferential attachment dynamics [11], which is consistent with
the fact that new PWID network members tend to join a particular injector network
via someone who is already an influential part of it.
Henceforth, we assume that the social network of PWID admits a scale-free
topology. In particular, one can write ρ(k) ∼ k−α where α is called scale parameter.
However, according to [12], it appears that power laws with exponential cutoff tend to fit
natural networks better than pure power laws, as almost surely there are no individuals
with an extremely large number of partners. Thus, based on this result and for an
arbitrary cutoff κ, one can write:
ρ(k) =
k−αe−k/κ
Liα (e−1/κ)
where Liα is the polylogarithm of order α.
2.2. Incorporating contact with HIV-infected individuals
The model developed in the previous subsection does not take into account the fact
that among PWID, people infected by HCV are often co-infected by HIV (human
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Figure 3: Compartmental model of HCV’s natural history with HIV
coinfection.
S, susceptible; A, acute HCV infection; C, chronic HCV infection. Starred compartments
represent HIV infected individuals.
immunodeficiency virus), which greatly increases the risk of death [3].
Therefore, we introduce three new compartments representing individuals infected
only by HIV (S∗), individuals in the acute phase of the HCV infection and infected by
HIV (A∗) and individuals in the chronic phase of the HCV infection and infected by
HIV (C∗). We now have S(t) + A(t) + C(t) + S∗(t) + A∗(t) + C∗(t) = N .
We also define γ∗ and δ∗, the recovery and death rates of HCV for people already
infected by HIV. As well as β∗ = ω × pi∗ the transmission rate of HIV, β† = ω × pi† the
transmission rate of both HCV and HIV and p∗ the spontaneous clearance of HCV for
people infected by HIV. Finally, we write µ∗ for the mortality rate of PWID infected by
HIV. A visual representation of the model is given in Figure 3. As previously, propor-
tions of the different quantities are denoted with small letters.
We now introduce the probabilities that an individual with degree k has an infected
partner whichever the infection. Hence, we have the probability that an individual with
degree k has an HCV infected partner:
θk(t) =
N−1∑
k′=1
ρN(k
′|k)
(
ak′(t) + ck′(t) + a
∗
k′(t) + c
∗
k′(t)
)
, (2.6)
the probability that an individual with degree k has an HIV infected partner:
θ∗k(t) =
N−1∑
k′=1
ρN(k
′|k)
(
s∗k′(t) + a
∗
k′(t) + c
∗
k′(t)
)
, (2.7)
and the probability that an individual with degree k has an HCV/HIV co-infected
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partner:
θ∗∗k (t) =
N−1∑
k′=1
ρN(k
′|k)
(
a∗k′(t) + c
∗
k′(t)
)
. (2.8)
From those equations and based on the model of Figure 3, one easily rewrites (2.3):
dsk(t)
dt
= Λ− kβsk(t)θk(t)− kβ∗sk(t)θ∗k(t)− kβ†sk(t)θ∗∗k (t)
+pσak(t) + γck(t)− µsk(t), (2.9)
ds∗k(t)
dt
= −kβs∗k(t)θk(t) + kβ∗sk(t)θ∗k(t) + p∗σa∗k(t) + γ∗c∗k(t)− µ∗s∗k(t),
dak(t)
dt
= kβsk(t)θk(t)− (σ + µ)ak(t)− kβ∗ak(t)θ∗k(t),
da∗k(t)
dt
= kβs∗k(t)θk(t) + kβ
†sk(t)θ∗∗k (t) + kβ
∗ak(t)θ∗k(t)− (σ + µ∗)a∗k(t),
dck(t)
dt
= (1− p)σak(t)− kβ∗ck(t)θ∗k(t)− (γ + δ + µ)ck(t),
dc∗k(t)
dt
= (1− p∗)σa∗k(t) + kβ∗ck(t)θ∗k(t)− (γ∗ + δ∗ + µ∗)c∗k(t).
Such a framework allows for the study of an epidemic on a given network. However,
when dealing with a large population, it might be wiser to deal with several subnetworks
connected with each other. Indeed, when dealing with an epidemic, say at a country
scale, computing a subnetwork for each city and allowing human movements between
them might be more accurate than computing a single giant network. Based on this
hypothesis, we propose to study, in the next section, the spread of the epidemic of HCV
defined by (2.9) across several subnetworks.
3. Epidemic propagation on a metapopulation model
Metapopulation models, first described in [13], consist in modeling the interactions of
several spatially separated populations. Those models have been extensively used in
the field of epidemiology to describe the spread of infectious diseases at a large scale
by dividing the population into subpopulations corresponding to different households,
cities, etc. Depending on human movements, a subpopulation, or patch, containing
infected individuals is allowed to interact with other patches spreading the infection
to neighboring subpopulations. We refer the reader for instance to [1] and [2] for an
illustration of the role of the global aviation network in the spread of the SARS infection.
Here we adapt this type of model to study the spread of HCV on a network of
cities, assuming that the population of each city can be considered as a patch of a
global metapopulation model. Each subpopulation admits a scale-free structure as de-
fined in Section 2.1 and the spread of the virus is governed by the set of differential
equations (2.9). To keep things simple while making them concrete, we work in this
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A B
Figure 4: Networks of A and B with the additional nodes representing people
from A in B and vice versa.
Network of the city A (resp. B) in blue (resp. red) with the additional node of B (resp. A)
in red (resp. in blue) interacting with every node. The blue light arrow represents the
population travelling from A to B while the red light arrow represents the population
from B to A.
section on networks of two and three cities.
Two-city network. Let us consider two cities A and B with injecting drug populations
NA and NB respectively. Assuming that these populations are organized in scale-free
networks, we denote respectively by 〈kA〉 and 〈kB〉 their mean degree and by ρA(k) and
ρB(k) their degree distributions. We update the notations in (2.9) by adding subscripts
corresponding to cities, e.g. sA(t) and sB(t) denote the proportions of susceptible
individuals in cities A and B respectively.
To model the effect of B on the spread of the disease in A, we propose to add a
node in the network of A which is interacting with every node of A. In the same way,
we add an extra node into the network of B to model the effect of A on B. These extra
nodes allow the population of A (resp. B) to connect with the new individuals moving
from B to A (resp. from A to B). A visual representation of the process is given in
Figure 4.
The extra node in the network of A contains the main characteristics of B, i.e. the
proportion of infected individuals in B and τB,A the number of people travelling from
B to A. Similarly, the extra node in the network of B contains the main characteristics
of A. Hence, by focusing on the first equation of (2.9), one can write:
dsk,A(t)
dt
= −kβsk,A(t)θk,A(t)− kβ∗sk,A(t)θ∗k,A(t)− kβ†sk,A(t)θ∗∗k,A(t)− µsk,A(t)
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−sk,A(t)
(
τB,A
nA + τB,A
)
·
[
β
(
aB(t) + cB(t) + a
∗
B(t) + c
∗
B(t)
)
(3.1)
+β∗
(
s∗B(t) + a
∗
B(t) + c
∗
B(t)
)
+ β†
(
a∗B(t) + c
∗
B(t)
)]
+ pσak,A(t) + γck,A(t)
where nA is the population still alive in city A. In particular, nA is defined as:
nA = sA(t) + aA(t) + cA(t) + s
∗
A(t) + a
∗
A(t) + c
∗
A(t).
Three-city network. Let us introduce a third city C with population NC . As above,
we assume that C is organized in a scale-free network with mean degree 〈kC〉 and degree
distribution ρC(k). To model the interactions between A and C (resp. B and C), we
add another node in the graph of A (resp. B) containing the main characteristics of C.
See Figure 5 for a graphical visualization of the process in the particular case of A.
Adding the new node corresponding to city C, equation (3.1) becomes:
dsk,A(t)
dt
= −kβsk,A(t)θk,A(t)− kβ∗sk,A(t)θ∗k,A(t)− kβ†sk,A(t)θ∗∗k,A(t)− µsk,A(t) (3.2)
−sk,A(t)
∑
Φ∈{B,C}
(
τΦ,A
nA +
∑
Φ∈{B,C} τΦ,A
)
·
[
β
(
aΦ(t) + cΦ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
+β∗
(
s∗Φ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
+ β†
(
a∗Φ(t) + c
∗
Φ(t)
)]
+ pσak,A(t) + γck,A(t).
Full details of the complete set of differential equations are available in Appendix Ap-
pendix A.1.
4. Simulations
4.1. Parameter values
Let us first consider three abstract cities A, B and C which PWID communities of 10000,
8000 and 5000 injecting drug users respectively. Cities with larger populations tend to
be more attractive, so we use a constrained gravitational model [14] to determine the
proportion of a city’s travelling population driven to a particular city among all other
cities:
τA,B =
mpnAnB
nB + nC
where mp is the moving population percentage. Values of the different population
movements were rounded up and reported in Table 1. Those percentages were kept
low to account for the fact that the population of a given city is far greater than the
moving population.
As far as network parameters are concerned, very limited data is available for their
estimation. Hence, we use the values obtained by [9], which were α = 1.8 for the scale
parameter and 〈k〉 = 3.0 for the mean degree. Based on this, we initiate 1000 simulations
of the degree distribution with α = 1.8 and different values of the exponential cut-off
until reaching the value of 3.0 for the mean degree. The resulting cutoff was κ = 40.
Figure 6 illustrates the degree distribution of a network of N=10,000.
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A
Figure 5: Network of A with the additional nodes corresponding to cities B
and C.
The network of city A is represented in blue. The additional nodes corresponding to
cities B and C are represented in red and green respectively. The red light arrow
represents the population travelling from B to A while the green light arrow represents
the population travelling from C to A.
Destination
mp = 0.1% mp = 1%
A B C A B C
A 0 6 4 0 62 39
B 5 0 3 53 0 27
C 3 2 0 28 22 0
Table 1: Annual origin-destination matrix.
As illustrated on Figure 6, degrees may attain high values (> 102). Since the
model described in Appendix A.1 is degree based, a high degree can lead to a very large
amount of differential equations. Hence, for the sake of practicality, we decide to split
the population into four arbitrary groups: people with degree 1, people whose degree
lies between 2 and 5, people whose degree lies between 6 and 10 and people whose degree
is greater than 10.
The values of the transmission risks of HCV and HIV are difficult to estimate.
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Figure 6: Degree distribution of a scale-free network constituted of 10,000
nodes.
The degree distribution was computed for a network of 10,000 nodes based on a power
law distribution with exponential cutoff which parameters are α = 1.8 and κ = 40.
Several studies reported different values for the per contact probability of HCV
transmission among PWID, ranging from 0.5% to 10% (see [6, 15, 16, 17, 18]). As for
the transmission of HCV, we refer to [6] who estimated a transmission risk of 1% in a
network of PWID in Australia. Considering the transmission of HIV, we refer to [19] who
reported 63 transmissions for 10,000 exposures for the US epidemic. These transmission
risks represent the probabilities of getting infected per act of sharing needles. Assuming
that these probabilities are independent, the transmission risk pi† of both HCV and HIV
is given by pi† = pi × pi∗.
As for the frequency of needle/syringe sharing, difficulties arise when one tries to
obtain accurate estimations. Referring to [15] we choose the value of 16 sharing acts
per month. However, as this frequency is shared among the different partners of a given
individual, we assume a per-partner sharing frequency of 16/3 = 5.33, where 3 is the
mean number of partners.
The values of the transmission risks introduced above reflect somehow the true HCV
and HIV transmission risks for PWID. However, for illustrative purposes, we propose to
temporary choose greater values for those risks by multiplying the transmission risks pi,
pi∗ and pi† by some constant λ to observe the impact of migrating people on the spread
of the epidemic.
Considering the treatment of HCV, we decided to focus on the recent direct-acting
antivirals (DAAs) which leads to high recovery rates. Indeed, based on a recent ANRS
press release, the recovery rate of the new DAAs has been estimated up to 93% for
HCV/HIV co-infected patients (see [20]). Similar results were observed for HCV mono-
infected patients. Due to the fact that HCV is an asymptomatic disease, a large part of
HCV infected patients are not aware of their serostatus. Globally, this involves a very
low proportion of infected patients accessing to health care. Indeed, although France
has one of the highest treatment rates in Europe, this proportion hardly reaches 5.2%
(see [21]).
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As for the mortality rates of PWID infected by HCV, HIV or HCV and HIV, we
refer to the work of [22] who calculated all-cause and cause-specific crude mortality rates
(per 1000 person-years) and standardized mortality ratios for PWID in the Netherlands.
A summary of the parameters used in the model are given in Table 2.
Since we want to quantify the impact of the interactions between cities, we assume
that the epidemic starts in one of the three cities and observe the impact on the two
others. We initiate the epidemic with a relatively low number of infected individuals in
city A, that is sA(0) = 0.985, cA(0) = 0.01 (HCV mono-infected individuals in chronic
phase) and c∗A(0) = 0.005 (HIV/HCV co-infected individuals in chronic phase). The
values chosen for the initiation of the model are purely arbitrary.
Due to the random nature of the network framework, we will focus on the average
of each quantity over 1000 simulation runs.
Table 2: Parameters used in the model to simulate the spread of HCV.
Parameter Notation Value Source
Risk of transmission per contact
HCV, % pi 1 [6]
HIV, % pi∗ 0.63 [19]
HCV and HIV, % pi† 6.3× 10−5 –
Semi-annual HCV spontaneous clearance
HCV mono-infected, % p 26 [23]
HCV/HIV co-infected, % p∗ 10 [24]
Annual risk of death
HCV/HIV uninfected,‰ µ 10.4 [22]
HCV mono-infected,‰ δ 22.7 [22]
HIV mono-infected,‰ µ∗ 44.3 [22]
HCV/HIV co-infected,‰ δ∗ 54.9 [22]
Network characteristics
Mean degree 〈k〉 3.0 [9]
Scale parameter α 1.8 [9]
Exponential cutoff κ 40 –
Anti-HCV treatment characteristics
Recovery rate, % ν 93 [20]
Proportion of treated patients, % q 5.2 [21]
Other parameters
Per-partner sharing frequency, per month ω 5.33 [15]
Duration of the acute phase, years 1/σ 1/2 [23]
Unit time, years – 1 –
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4.2. Results on an abstract three-city network
Figures 7, 8 and 9 display the evolution of the susceptible, the HCV mono-infected
and HIV/HCV co-infected populations in the whole system (cities A, B and C). The
different curves of the three figures represent the population dynamics when no migration
is assumed (blue markers), 0.1% of the population is migrating (red markers) and 1%
of the population is migrating (green markers). Each quantity displayed in Figures 7, 8
and 9 is the sum of the corresponding quantity over the four degree groups.
In Figure 7, one sees that the susceptible population gradually depletes with the
percentage of migrating population. As more and more people move from city A, the
epidemic spreads faster and has a stronger impact on cities B and C. As expected, the
spread of the epidemic is even stronger when coefficient α increases i.e. when the scale
parameter of the degree distribution increases and individuals with larger degrees are
present. One can see that the blue curves reach a minimum value between 60% and
70%. This phenomenon is due to the fact that the susceptible populations in cities B
and C stay intact (no initial infected individual nor migration from infected cities).
In Figure 8, one observes the same dynamics as in Figure 7. The proportion of
HCV mono-infected individuals in the population is greatly impacted by the percentage
of migrating people and by the value of α. Similarly, the blue curves here correspond
to the proportion of HCV mono-infected individuals in the city A. This explains why
that proportion is never higher than 33.3%.
Lastly, Figure 9 exhibits the same evolutions as the two previous figures. One can
particularly observe on Figure 9 that the evolution of the HIV/HCV co-infected popu-
lation is greater than the evolution of the HCV mono-infected population of Figure 8.
This is due to the fact that, contrary to HCV, no treatment for HIV is considered in
the model. Thus, each HCV mono-infected individual tends to get also infected by HIV
as time goes by.
In the next section we study the spread of the infection on the network of France’s
100 largest urban centers. In particular, we examine the influence of the starting point
of the epidemic.
4.3. Results on the network of France’s 100 largest urban areas
We generalize the metapopulation model of Section 4.1 by studying the spread of
HCV across a whole country: France. As we want our predictions to be relatively
accurate without considering every single city, we choose to focus on the first hundred
biggest urban areas in France (metropolitan France only) for a population of 43,187,838
individuals in 2012. Indeed, in [25] three main drivers of mobility for PWID were
identified: legal problems, entering drug treatment programs, and drug tourism. We
assume that the great majority of PWID tend to move towards and between the main
urban areas.
Then, the population of these urban areas is multiplied by the prevalence of PWID
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Figure 7: Mean evolution of the susceptible population in the whole system.
The different curves represent the mean quantities over 1000 simulation runs. Blue
curves represent the evolution of the susceptible population when no interactions
between the cities are allowed (mp = 0%), red curves represent the evolution of the
susceptible population assuming interactions up to 0.1% of the populations (mp =
0.1%) and green curves represent the evolution of the susceptible population assuming
interactions up to 1% of the populations (mp = 1%).
in France estimated at 5.9 ‰ by the OFDT (Observatoire franc¸ais des drogues et des
toxicomanies, the French monitoring centre for drugs & drug addiction) in 2006 [26].
Since this prevalence has been estimated for the population aged 15 to 64 (63, 8% of the
total French population in 2012, i.e 40,433,870 individuals), we multiply the population
of the French urban areas by 40433870/43187838 = 0.94 for both populations to match.
The original populations retained for the simulations are reported in Appendix Ap-
pendix A.2.
Regarding the origin-destination matrix, no data is available for the annual migra-
tion of PWID. Hence, we refer to a French database of residential mobility during a
five-year period published on the website of INSEE (Institut national de la statistique et
des e´tudes e´conomiques, the French office for national statistics). Values are divided by
5 and rounded to obtain an annual origin-destination matrix. As we focus on PWID,
values are multiplied by 5.9‰.
To study the impact of migrating populations and of the size of the initial city
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Figure 8: Mean evolution of the HCV mono-infected population in the whole
system.
The different curves represent the mean quantities over 1000 simulation runs. Blue
curves represent the evolution of the HCV mono-infected population when no
interactions between the cities are allowed (mp = 0%), red curves represent the
evolution of the HCV mono-infected population assuming interactions up to 0.1% of the
populations (mp = 0.1%) and green curves represent the evolution of the HCV mono-
infected population assuming interactions up to 1% of the populations (mp = 1%).
infected on the spread of the infection, we shall consider two different starting points.
We first choose Paris as a starting point since this city has the highest level of interactions
with nearly all other French cities. To select the second starting point, we need a city
which possesses a far lower level of interactions with all cities other than Paris. However,
to prevent the snowball effect, it is better to also focus on a city which has very limited
interactions with Paris. Hence, we choose Forbach, a small urban area in the North-
Eastern part of France, as the starting point in a second set of simulations.
Referring to Section 4.1, we set the proportion of susceptible individuals to 98.5%
in the city where the epidemic starts. The proportions of HCV mono-infected (chronic
phase) and HIV mono-infected patients are set to 1% and 0.5% respectively in that
same city. All other cities are initiated at 100% of susceptible individuals. Similarly,
we assume that each urban area is organized according to a scale-free network, the
degree distribution of which follows a power law with exponential cutoff and a multi-
plicative constant λ of 10. Parameters considered for this model are reported in Table 2.
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Figure 9: Mean evolution of the HIV/HCV co-infected population in the
whole system.
The different curves represent the mean quantities over 1000 simulation runs. Blue
curves represent the evolution of the HIV/HCV co-infected population when no
interactions between the cities are allowed (mp = 0%), red curves represent the
evolution of the HIV/HCV co-infected population assuming interactions up to 0.1% of
the populations (mp = 0.1%) and green curves represent the evolution of the HIV/HCV
co-infected population assuming interactions up to 1% of the populations (mp = 1%).
Results. Evolution of the different mean quantities are represented in Figure 10 where
the two different scenarios are exhibited in plain and dashed curves. One notices that,
as expected, the epidemic spreads much more easily to the whole country when starting
from Paris rather than Forbach. Indeed, as Paris has many more interactions with
other urban areas than Forbach, the epidemic spreads faster. Particularly, one sees that
the proportion of susceptible individuals depletes rapidly between the third and the
eighth year when the epidemic starts in Paris while this proportion depletes between
the seventh and the fourteenth year when the epidemic starts in Forbach. Similarly, one
oberves that the proportion of HCV mono-infected patients increases over a few years
and then decreases due to the superinfection with HIV.
Figures 11 and 12 give a comparison of the spread of the infection in the country.
As intuitively expected, the epidemic spreads further and faster when starting in Paris.
Indeed, ten years after the beginning of the epidemic, the high majority of urban
areas admits a proportion of HCV infected individuals (mono-infection or co-infection)
superior to 40% when the epidemic outbreak takes place in Paris. For comparison, when
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the epidemic breaks out in Forbach, not all urban areas are affected by the infection
even after ten years. Finally, one notes that the last epidemic-affected city is Cluses
in both cases. This can be explained by the fact that this urban area presents the
lowest level of interaction with other French cities (it only interacts significantly with
Gene`ve-Annemasse).
Paris as starting point Susceptible HCV mono-infected HIV/HCV co-infected
Forbach as starting point Susceptible HCV mono-infected HIV/HCV co-infected
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Figure 10: Mean evolution of the population dynamics in France.
The different curves represent the mean quantities over 1000 simulations. Dotted curves
represent the evolution of the French population when Forbach is chosen as the epidemic
starting point while (+) markers represent the evolution of the French population
when Paris is chosen as the epidemic starting point. The blue markers represent the
susceptible population while the red and the green markers represent the HCV mono-
infected and the HIV/HCV co-infected populations respectively
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No infected individual Less than 20% of infected individuals
From 20% to 40% of infected individuals From 40% to 60% of infected individuals
From 60% to 80% of infected individuals More than 80% of infected individuals
(a) One year after epidemic start (b) Three years after epidemic start
(c) Five years after epidemic start (d) Ten years after epidemic start
Figure 11: Evolution of the spread of HCV in France with an epidemic start
in Paris.
Estimations of the proportions of HCV infected individuals in France over 1000
simulations. Each colored dot represents a French urban area. Starting point was 98.5%
of susceptible, 1% of HCV infected individuals and 0.5% of HIV infected individuals in
Paris. Every other city started at 100% of susceptible individuals.
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No infected individual Less than 20% of infected individuals
From 20% to 40% of infected individuals From 40% to 60% of infected individuals
From 60% to 80% of infected individuals More than 80% of infected individuals
(a) One year after epidemic start (b) Three years after epidemic start
(c) Five years after epidemic start (d) Ten years after epidemic start
Figure 12: Evolution of the spread of HCV in France with an epidemic start
in Forbach.
Estimations of the proportions of HCV infected individuals in France over 1000
simulations. Each colored dot represents a French urban area. Starting point was 98.5%
of susceptible, 1% of HCV infected individuals and 0.5% of HIV infected individuals in
Forbach. Every other city started at 100% of susceptible individuals.
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5. Conclusion
In this paper, we have introduced as a metapopulation model a compartmental model
for the propagation of HCV on a network of networks, representing PWID populations
in distinct but interconnected French cities.
Tested on a three-city network, it exhibits, as expected, an epidemic spread
correlated with the amount of interactions between the cities: the epidemic grows faster
and stronger when the amount of interactions between cities is high. Applied on a
network of 100 interconnected urban areas (corresponding to the 100 lqrgest urban
areas in France), the model yields very sensible stylized facts concerning the epidemic
spread, in particular when chosing as starting points two different cities differing from
each other by the amount of interactions they have with other urban areas. In particular,
sensible differences are observed in terms of prevalence and propagation.
Our model combines two important features. First, it takes into account hetero-
geneities in the PWID population, which plays a crucial role in the transmission process.
Secondly, it uses a metapopulation model to describe the infectious dynamics at a coun-
try scale.
Indeed, the use of a metapopulation model allows to divide the general PWID population
into several PWID subpopulations and thus to better handle population heterogeneities
at the subpopulation level with a contact network. Also, the model is relatively easy
to handle, thanks to the use of extra-nodes working, in each network coorsedpong to a
city, as proxys for individuals coming from other cities.
Having obtained sensible outcomes with this model, our next steps will be to
obtain reliable data in order to calibrate and test it further. This is particularly
challenging when dealing with PWID population. Indeed, whether it be needle sharing
behavior for the estimation of HCV transmission or the degree of each individual for the
establishment of a reasonable contact network, the lack of data forced us to make strong
assumptions. Moreover, no cessation of treatment was taken into account despite the
fact that the rate of non-compliance among PWID may be significant. Regarding the
population moving from city to city, our only source was a French database of residential
mobility which may misestimate the actual migrating dynamics of the PWID population.
It will also be of particular interest to explore part of the phase space arising
when the values chosen for certain crucial parameters (such as the transmission rate)
are allowed to vary across ranges away from their current reported or assumed typical
value. This may reveal some unexpected transitions and critical values in the phase
space corresponding to some of the parameters.
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Appendix
Appendix A.1. Differential equations
dsk,·(t)
dt
= Λ− kβsk,·(t)θk,·(t)− kβ∗sk,·(t)θ∗k,·(t)− kβ†sk,·(t)θ∗∗k,·(t)− µsk,·(t)
−sk,·(t)
∑
Φ
(
τΦ,·
n· +
∑
Φ τΦ,·
)
·
[
β
(
aΦ(t) + cΦ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
+β∗
(
s∗Φ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
+ β†
(
a∗Φ(t) + c
∗
Φ(t)
)]
+ pσak,·(t) + γck,·(t),
ds∗k,·(t)
dt
= −kβs∗k,·(t)θk,·(t) + kβ∗sk,·(t)θ∗k,·(t) + p∗σa∗k,·(t) + γ∗c∗k,·(t)− µ∗s∗k,·(t)
+
∑
Φ
(
τΦ,·
n· +
∑
Φ τΦ,·
)
·
[
β∗sk,·(t)
(
s∗Φ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
− βs∗k,·(t)
(
aΦ(t) + cΦ(t) + a
∗
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∗
Φ(t)
)]
,
dak,·(t)
dt
= kβsk,·(t)θk,·(t)− (σ + µ)ak,·(t)− kβ∗ak,·(t)θ∗k,·(t)
+βsk,·(t)
∑
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∑
Φ τΦ,·
)
·
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aΦ(t) + cΦ(t) + a
∗
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∗
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da∗k,·(t)
dt
= kβs∗k,·(t)θk,·(t) + kβ
†sk,·(t)θ∗∗k,·(t) + kβ
∗ak,·(t)θ∗k,·(t)− (σ + µ∗)a∗k,·(t)
+
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,
dck,·(t)
dt
= (1− p)σak,·(t)− kβ∗ck,·(t)θ∗k,·(t)− (γ + δ + µ)ck,·(t)
−β∗(ak,·(t) + ck,·(t))
∑
Φ
(
τΦ,·
n· +
∑
Φ τΦ,·
)
·
(
s∗Φ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
,
dc∗k,·(t)
dt
= (1− p∗)σa∗k,·(t) + kβ∗ck,·(t)θ∗k,·(t)− (γ∗ + δ∗ + µ∗)c∗k,·(t)
+β∗ck,·(t)
∑
Φ
(
τΦ,·
n· +
∑
Φ τΦ,·
)
·
(
s∗Φ(t) + a
∗
Φ(t) + c
∗
Φ(t)
)
.
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Appendix A.2. The main French urban areas
Urban area Population Urban area Population
Paris 12,341,418 Saint-Brieuc 171,721
Lyon 2,214,068 Be´ziers 165,498
Marseille - Aix-en-Provence 1,727,070 Montbe´liard 162,326
Toulouse 1,270,760 Niort 152,721
Lille† 1,166,452 Vannes 150,860
Bordeaux 1,158,431 Chartres 145,735
Nice 1,004,914 Bourges 139,968
Nantes 897,713 Thionville 135,627
Strasbourg† 768,868 Chaˆlon-sur-Saoˆne 133,557
Rennes 690,467 Boulogne-sur-Mer 133,062
Grenoble 679,863 Maubeuge 129,931
Rouen 658,285 Arras 128,784
Toulon 611,237 Colmar 127,625
Montpellier 569,956 Blois 127,053
Douai - Lens 540,981 Calais 126,266
Avignon 515,536 Quimper 125,487
Saint-Etienne 512,830 Beauvais 125,095
Tours 483,744 Bourg-en-Bresse 122,806
Clermont-Ferrand 469,922 Laval 121,399
Nancy 434,479 La Roche-sur-Yon 117,965
Orle´ans 423,123 Creil 117,654
Angers 403,633 Cherbourg-Octeville 116,517
Caen 403,765 Tarbes 115,557
Metz 389,700 Belfort 114,077
Dijon 377,590 Ale`s 113,769
Be´thune 368,633 Vienne 112,334
Valenciennes† 367,094 Agen 111,663
Le Mans 344,893 Saint-Quentin 111,474
Reims 317,611 Evreux 111,449
Brest 314,844 Roanne 107,209
Perpignan 309,962 Charleville-Me´zie`res 106,835
Amiens 293,671 Montauban 105,654
Gene`ve - Annemasse† 292,180 Cholet 104,917
Le Havre 290,890 Pe´rigueux 102,417
Bayonne† 288,359 Sarrebruck - Forbach† 101,806
Mulhouse 284,739 Nevers 101,586
Limoges 282,971 Brive-la-Gaillarde 101,435
Nıˆmes 259,348 Ajaccio 100,643
Dunkerque 257,773 Maˆcon 99,873
Poitiers 255,831 Carcassonne 97,801
Besanc¸on 246,841 Albi 97,667
Pau 240,857 Compie`gne 97,502
Annecy 221,111 Bastia 93,971
Chambe´ry 217,356 Epinal 93,891
Lorient 215,591 Fre´jus 93,562
Saint-Nazaire 213,083 Baˆle - Saint-Louis† 93,018
La Rochelle 207,211 Chteauroux 92,723
Troyes 191,505 Auxerre 92,307
Angouleˆme 180,593 Se`te 91,101
Valence 175,636 Cluses 90,872
Table A1: Population of the French urban areas based on census data for the
year 2012.
† Only the French part is considered.
